Capital World Investors 13D and 13G filings for Biohaven Pharmaceutical Holding Company Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-06-10 2:57 pm Sale | 2022-06-10 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN | Capital World Investors | 3,446,156 4.900% | -3,629,358 (-51.29%) | Filing |
| 2022-05-10 11:56 am Purchase | 2022-05-10 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN | Capital World Investors | 7,075,514 10.000% | 897,505 (+14.53%) | Filing |
| 2022-02-11 2:48 pm Purchase | 2022-02-14 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN | Capital World Investors | 6,178,009 9.400% | 1,528,561 (+32.88%) | Filing |
| 2021-02-16 2:04 pm Purchase | 2021-02-16 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN | Capital World Investors | 4,649,448 7.800% | 4,649,448 (New Position) | Filing |